<?xml version="1.0" encoding="UTF-8"?>
<p id="Par98">Patients must not be enrolled on other clinical trials involving anticancer treatment, without the agreement of the Coordinating Principal Investigators (CPIs) of both studies, and if the other study has a therapeutic intervention, the patient must be beyond the primary endpoint of that trial and not continuing to receive study treatment.</p>
